tickdelta
tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

NDSNNordson Corporation

Industrials · Industrial Machinery · Nasdaq
NDSN quote by TradingView
Compare with peers → Embed
FY2025 at a glance

Sales up 3.8%, free cash flow up to $661.1M

XBRL, from each 10-K
RevenueStatements ↓
$2.8B
from $2.7B in FY2024
FY2016FY2025
Net incomeStatements ↓
$484.5M
from $467.3M in FY2024
FY2016FY2025
Free cash flowStatements ↓
$661.1M
from $491.8M in FY2024
FY2016FY2025
EPS (diluted)Statements ↓
$8.51
from $8.11 in FY2024
FY2016FY2025
Operating marginStatements ↓
25.5%
from 25.1% in FY2024
FY2016FY2025
Total debtStatements ↓
$2.0B
from $2.2B in FY2024
FY2016FY2025
Price and key numbers

The latest figures

All key numbers (42, from the latest 10-K and 10-Q) From EDGAR
EPS (ttm)9.88Sales (ttm)3.0BNet income (ttm)555.2MSales growth+3.8%EPS growth+4.9%Sales Q/Q+10.3%
Free cash flow724.0MGross margin55.3%Oper. margin26.9%Net margin18.6%FCF margin24.3%ROE17.0%
ROA9.3%R&D / sales2.4%Dividend3.16Debt/Eq0.59Curr. ratio1.82Cash113.4M
Op. cash flow (ttm)773.4MEBITDA791.0MEBITDA margin28.3%Net debt1.8BQuick ratio1.21Interest cover6.83
ROIC11.1%Payout ratio37.1%Tax rate18.9%Stock pay / sales0.7%Shares out.55.7MShares Y/Y-1.2%
Book / share58.69Cash / share2.04Sales / share53.50Asset turnover0.50Inventory turns2.81Days sales out.77
Sales 3Y CAGR+2.5%Sales 5Y CAGR+5.6%EPS 3Y CAGR-1.1%EPS 5Y CAGR+14.8%Employees8,000Sales / employee372K

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Changes in the numbers

FY2025 against FY2024
  • Free cash flow rose 34%$491.8M → $661.1M · Cash from operations − capital expenditure · 10-K ↗
What management wrote about it → · Every company →

NDSN against Industrials peers

Ten years, side by side → · All 83 →
GrowthProfitBalanceCleanInsiders
NDSNPeer median

Each side 0 to 100, ranked against every company we cover: relative position on reported figures, not a buy score. How

Every dot is one of the 83 companies, the better end on the right. Hover a dot for the company.

Sales growth
+3.8%49th of 82 · median +4.8%
Net margin
18.6%16th of 82 · median 13.0%
Return on equity
17.0%49th of 77 · median 24.9%
Free cash flow margin
24.3%7th of 79 · median 13.0%
Debt / equity (less is better)
0.5931st of 72 · median 0.72
NDSN and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthGross marginNet marginROEFCF marginDebt / equity
NDSN Nordson Corporation$3.0B +3.8%55.3%18.6%17.0%24.3%0.59
BE Bloom Energy$3.8B +37.3%32.3%13.7%27.1%11.4%1.28
AOS A. O. Smith$3.8B +0.3%38.6%13.0%27.1%14.8%0.37
IEX IDEX Corporation$3.7B +5.8%44.9%14.6%13.3%18.2%0.44
AXON Axon Enterprise$3.4B +33.5%58.5%7.6%6.9%2.4%0.76
VRSK Verisk Analytics$3.2B +6.6%70.2%27.7%-34.6%-
Where each dollar goes

From $2.4B of sales to $454.4M of profit

FY2021, from the 10-K income statement
Revenue to Gross profit: $1.3BRevenue to Cost of revenue: $1.0BGross profit to Operating profit: $615.1MGross profit to Operating expenses: $709.0MOperating profit to Net profit: $454.4MOperating profit to Tax & other: $160.8MOperating expenses to R&D: $59.4MOperating expenses to Sales, admin & other: $649.5M Revenue: $2.4B Revenue$2.4B +11% Y/Y Gross profit: $1.3B · 56% margin Gross profit$1.3B56% margin Cost of revenue: $1.0B · 44% of revenue Cost of revenue$1.0B44% of revenue Operating profit: $615.1M · 26% margin Operating profit$615.1M26% margin +76% Y/Y Operating expenses: $709.0M · 30% of revenue Operating expenses$709.0M30% of revenue Net profit: $454.4M · 19% margin Net profit$454.4M19% margin +82% Y/Y Tax & other: $160.8M · 7% of revenue Tax & other$160.8M7% of revenue R&D: $59.4M · 3% of revenue R&D$59.4M3% of revenue Sales, admin & other: $649.5M · 27% of revenue Sales, admin & other$649.5M27% of revenue

Swipe sideways for the whole flow →

From $2.6B of sales to $513.1M of profit

FY2022, from the 10-K income statement and revenue by segment
Industrial Precisions Solutions to Revenue: $1.3BMedical Fluid Systems to Revenue: $690.2MAdvanced Technology Systems to Revenue: $562.9MRevenue to Gross profit: $1.4BRevenue to Cost of revenue: $1.2BGross profit to Operating profit: $702.4MGross profit to Operating expenses: $724.2MOperating profit to Net profit: $513.1MOperating profit to Tax & other: $189.3MOperating expenses to R&D: $52.5MOperating expenses to Sales, admin & other: $671.6M Industrial Precisions Solutions: $1.3B · 52% Industrial Precisions S…$1.3B52% Medical Fluid Systems: $690.2M · 27% Medical Fluid Systems$690.2M27% Advanced Technology Systems: $562.9M · 22% Advanced Technology Sys…$562.9M22% Revenue: $2.6B Revenue$2.6B +10% Y/Y Gross profit: $1.4B · 55% margin Gross profit$1.4B55% margin Cost of revenue: $1.2B · 45% of revenue Cost of revenue$1.2B45% of revenue Operating profit: $702.4M · 27% margin Operating profit$702.4M27% margin +14% Y/Y Operating expenses: $724.2M · 28% of revenue Operating expenses$724.2M28% of revenue Net profit: $513.1M · 20% margin Net profit$513.1M20% margin +13% Y/Y Tax & other: $189.3M · 7% of revenue Tax & other$189.3M7% of revenue R&D: $52.5M · 2% of revenue R&D$52.5M2% of revenue Sales, admin & other: $671.6M · 26% of revenue Sales, admin & other$671.6M26% of revenue

Swipe sideways for the whole flow →

From $2.6B of sales to $487.5M of profit

FY2023, from the 10-K income statement and revenue by segment
Industrial Precisions Solutions to Revenue: $1.3BMedical Fluid Systems to Revenue: $660.3MAdvanced Technology Systems to Revenue: $671.2MRevenue to Gross profit: $1.4BRevenue to Cost of revenue: $1.2BGross profit to Operating profit: $672.8MGross profit to Operating expenses: $752.6MOperating profit to Net profit: $487.5MOperating profit to Tax & other: $185.3MOperating expenses to R&D: $71.4MOperating expenses to Sales, admin & other: $681.2M Industrial Precisions Solutions: $1.3B · 49% Industrial Precisions S…$1.3B49% Medical Fluid Systems: $660.3M · 25% Medical Fluid Systems$660.3M25% Advanced Technology Systems: $671.2M · 26% Advanced Technology Sys…$671.2M26% Revenue: $2.6B Revenue$2.6B +1% Y/Y Gross profit: $1.4B · 54% margin Gross profit$1.4B54% margin Cost of revenue: $1.2B · 46% of revenue Cost of revenue$1.2B46% of revenue Operating profit: $672.8M · 26% margin Operating profit$672.8M26% margin −4% Y/Y Operating expenses: $752.6M · 29% of revenue Operating expenses$752.6M29% of revenue Net profit: $487.5M · 19% margin Net profit$487.5M19% margin −5% Y/Y Tax & other: $185.3M · 7% of revenue Tax & other$185.3M7% of revenue R&D: $71.4M · 3% of revenue R&D$71.4M3% of revenue Sales, admin & other: $681.2M · 26% of revenue Sales, admin & other$681.2M26% of revenue

Swipe sideways for the whole flow →

From $2.7B of sales to $467.3M of profit

FY2024, from the 10-K income statement and revenue by segment
Industrial Precisions Solutions to Revenue: $1.4BMedical Fluid Systems to Revenue: $695.5MAdvanced Technology Systems to Revenue: $595.6MRevenue to Gross profit: $1.5BRevenue to Cost of revenue: $1.2BGross profit to Operating profit: $674.0MGross profit to Operating expenses: $812.1MOperating profit to Net profit: $467.3MOperating profit to Tax & other: $206.7MOperating expenses to R&D: $65.0MOperating expenses to Sales, admin & other: $747.1M Industrial Precisions Solutions: $1.4B · 52% Industrial Precisions S…$1.4B52% Medical Fluid Systems: $695.5M · 26% Medical Fluid Systems$695.5M26% Advanced Technology Systems: $595.6M · 22% Advanced Technology Sys…$595.6M22% Revenue: $2.7B Revenue$2.7B +2% Y/Y Gross profit: $1.5B · 55% margin Gross profit$1.5B55% margin Cost of revenue: $1.2B · 45% of revenue Cost of revenue$1.2B45% of revenue Operating profit: $674.0M · 25% margin Operating profit$674.0M25% margin +0% Y/Y Operating expenses: $812.1M · 30% of revenue Operating expenses$812.1M30% of revenue Net profit: $467.3M · 17% margin Net profit$467.3M17% margin −4% Y/Y Tax & other: $206.7M · 8% of revenue Tax & other$206.7M8% of revenue R&D: $65.0M · 2% of revenue R&D$65.0M2% of revenue Sales, admin & other: $747.1M · 28% of revenue Sales, admin & other$747.1M28% of revenue

Swipe sideways for the whole flow →

From $2.8B of sales to $484.5M of profit

FY2025, from the 10-K income statement and revenue by segment
Industrial Precisions Solutions to Revenue: $1.3BMedical Fluid Systems to Revenue: $835.4MAdvanced Technology Systems to Revenue: $624.5MRevenue to Gross profit: $1.5BRevenue to Cost of revenue: $1.3BGross profit to Operating profit: $711.7MGross profit to Operating expenses: $828.1MOperating profit to Net profit: $484.5MOperating profit to Tax & other: $227.3MOperating expenses to R&D: $68.2MOperating expenses to Sales, admin & other: $759.8M Industrial Precisions Solutions: $1.3B · 48% Industrial Precisions S…$1.3B48% Medical Fluid Systems: $835.4M · 30% Medical Fluid Systems$835.4M30% Advanced Technology Systems: $624.5M · 22% Advanced Technology Sys…$624.5M22% Revenue: $2.8B Revenue$2.8B +4% Y/Y Gross profit: $1.5B · 55% margin Gross profit$1.5B55% margin Cost of revenue: $1.3B · 45% of revenue Cost of revenue$1.3B45% of revenue Operating profit: $711.7M · 25% margin Operating profit$711.7M25% margin +6% Y/Y Operating expenses: $828.1M · 30% of revenue Operating expenses$828.1M30% of revenue Net profit: $484.5M · 17% margin Net profit$484.5M17% margin +4% Y/Y Tax & other: $227.3M · 8% of revenue Tax & other$227.3M8% of revenue R&D: $68.2M · 2% of revenue R&D$68.2M2% of revenue Sales, admin & other: $759.8M · 27% of revenue Sales, admin & other$759.8M27% of revenue

Swipe sideways for the whole flow →

Where each $100 of sales went

FY2021
FY2022
FY2023
FY2024
FY2025
  • Cost of revenue
  • R&D
  • Sales, admin & other
  • Tax & other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement →

Profitability

3 of 3
  • ✓
    Net margin above the peer median18.6% vs 13.0%
  • ✓
    Return on equity above 15%17.0%
  • ✓
    A profit in every one of 10 years
Net margin, FY2016 to FY2025: 15.0% → 17.4%

Balance sheet

4 of 4
  • ✓
    Interest covered more than 5 timesOperating income is 6.8× interest expense
  • ✓
    Debt smaller than equityDebt / equity 0.59 on the latest balance sheet (peer median 0.72)
  • ✓
    Current assets cover current liabilitiesCurrent ratio 1.82
  • ✓
    Net debt under 3 years of free cash flow$1.8B net debt, 2.5 years
Debt / equity at each year end, FY2016 to FY2025: 1.15 → 0.66
What the debt is made of ↓

Cash and shareholders

4 of 4
  • ✓
    Free cash flow positive in every one of 10 years$661.1M last year
  • ✓
    Share count down over 5 years−2.7%
  • ✓
    Dividend per share up over 5 years$1.53 → $3.16
  • ✓
    Cash from operations above net income$719.2M vs $484.5M
Free cash flow, FY2016 to FY2025: 273.8M → 661.1M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

Debt

$1.5B of principal due, schedule of Oct 31, 2025

Repayment schedule →

From the balance sheet in the latest 10-K or 10-Q (XBRL). When each part falls due, year by year, and the debt note's own lines are on the Debt tab.

Revenue and net income, FY2016 to FY2025

Revenue 2.8B Net income 484.5M
FY2016 revenue 1.8B · Revenues, 0001564590-18-030928 FY2016 net income 271.8M · NetIncomeLoss, 0001564590-18-030928 1.8B FY2016 FY2017 revenue 2.1B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001564590-19-045927 FY2017 net income 295.8M · NetIncomeLoss, 0001564590-19-045927 2.1B FY2017 FY2018 revenue 2.3B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000072331-20-000024 FY2018 net income 377.4M · NetIncomeLoss, 0000072331-20-000024 2.3B FY2018 FY2019 revenue 2.2B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000072331-21-000079 FY2019 net income 337.1M · NetIncomeLoss, 0000072331-21-000079 2.2B FY2019 FY2020 revenue 2.1B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000072331-22-000185 FY2020 net income 249.5M · NetIncomeLoss, 0000072331-22-000185 2.1B FY2020 FY2021 revenue 2.4B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000072331-23-000242 FY2021 net income 454.4M · NetIncomeLoss, 0000072331-23-000242 2.4B FY2021 FY2022 revenue 2.6B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000072331-24-000177 FY2022 net income 513.1M · NetIncomeLoss, 0000072331-24-000177 2.6B FY2022 FY2023 revenue 2.6B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000072331-25-000144 FY2023 net income 487.5M · NetIncomeLoss, 0000072331-25-000144 2.6B FY2023 FY2024 revenue 2.7B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000072331-25-000144 FY2024 net income 467.3M · NetIncomeLoss, 0000072331-25-000144 2.7B FY2024 FY2025 revenue 2.8B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000072331-25-000144 FY2025 net income 484.5M · NetIncomeLoss, 0000072331-25-000144 2.8B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. Full financials →

Statements

Income statement, balance sheet and cash flow

XBRL, each 10-K and 10-Q

NDSN's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Annual Quarterly
Revenue2.8B
FY2016: 1.8BFY2017: 2.1BFY2018: 2.3BFY2019: 2.2BFY2020: 2.1BFY2021: 2.4BFY2022: 2.6BFY2023: 2.6BFY2024: 2.7BFY2025: 2.8B FY2017FY2019FY2021FY2023FY2025
Net income484.5M
FY2016: 271.8MFY2017: 295.8MFY2018: 377.4MFY2019: 337.1MFY2020: 249.5MFY2021: 454.4MFY2022: 513.1MFY2023: 487.5MFY2024: 467.3MFY2025: 484.5M FY2017FY2019FY2021FY2023FY2025
Free cash flow661.1M
FY2016: 273.8MFY2017: 285.2MFY2018: 414.8MFY2019: 318.6MFY2020: 451.9MFY2021: 507.6MFY2022: 461.7MFY2023: 606.7MFY2024: 491.8MFY2025: 661.1M FY2017FY2019FY2021FY2023FY2025
EPS (diluted)8.51
FY2016: 4.73FY2017: 5.08FY2018: 6.40FY2019: 5.79FY2020: 4.27FY2021: 7.74FY2022: 8.81FY2023: 8.46FY2024: 8.11FY2025: 8.51 FY2017FY2019FY2021FY2023FY2025
Dividend per share3.16
FY2016: 0.99FY2017: 1.11FY2018: 1.25FY2019: 1.43FY2020: 1.53FY2021: 1.69FY2022: 2.18FY2023: 2.63FY2024: 2.82FY2025: 3.16 FY2017FY2019FY2021FY2023FY2025
Diluted shares56.9M
FY2016: 57.5MFY2017: 58.2MFY2018: 58.9MFY2019: 58.2MFY2020: 58.5MFY2021: 58.7MFY2022: 58.2MFY2023: 57.6MFY2024: 57.6MFY2025: 56.9M FY2017FY2019FY2021FY2023FY2025

Revenue by business segment

year to Oct 31, 2025
RevenueSharevs year before
Industrial Precisions Solutions 1.3B47.7% -4.8%
Medical Fluid Systems 835.4M29.9% +20.1%
Advanced Technology Systems 624.5M22.4% +4.9%

10-K 0000072331-25-000144, segment and revenue notes (XBRL).

Revenue by region

year to Oct 31, 2025
RevenueSharevs year before
Americas 1.2B43.2% +2.3%
UNITED STATES 922.7M33.1% +2.6%
Asia Pacific Excluding Japan 863.6M30.9% +10.0%
Europe 722.2M25.9% -0.5%

10-K 0000072331-25-000144, segment and revenue notes (XBRL).

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1.8B2.1B2.3B2.2B2.1B2.4B2.6B2.6B2.7B2.8B
Cost of revenue815.5M927.7M1.0B1.0B990.6M1.0B1.2B1.2B1.2B1.3B
R&D46.2M52.5M58.8M60.0M63.6M59.4M52.5M71.4M65.0M68.2M
SG&A605.1M672.9M733.7M709.0M693.6M709.0M724.2M752.6M812.1M815.5M
Operating income388.4M466.4M502.6M483.1M349.5M615.1M702.4M672.8M674.0M711.7M
Interest expense21.3M36.6M49.6M47.1M32.2M25.5M22.4M59.5M88.9M104.2M
Pretax income368.5M420.3M448.5M431.1M301.5M574.2M649.3M615.3M585.5M597.6M
Income tax96.7M124.5M71.1M94.0M52.0M119.8M136.2M127.8M118.2M113.2M
Net income271.8M295.8M377.4M337.1M249.5M454.4M513.1M487.5M467.3M484.5M
EPS (diluted)4.735.086.405.794.277.748.818.468.118.51
Diluted shares57.5M58.2M58.9M58.2M58.5M58.7M58.2M57.6M57.6M56.9M
Depreciation & amortization41.2M45.9M53.0M55.5M56.3M103.9M99.9M59.7M77.0M79.3M
EBITDA429.7M512.3M555.5M538.6M405.9M719.0M802.3M732.5M751.0M791.0M
Operating margin21.5%22.6%22.3%22.0%16.5%26.0%27.1%25.6%25.1%25.5%
Net margin15.0%14.3%16.7%15.4%11.8%19.2%19.8%18.5%17.4%17.4%
Revenue growth-+14.3%+9.1%-2.7%-3.3%+11.4%+9.7%+1.5%+2.3%+3.8%
EPS growth-+7.4%+26.0%-9.5%-26.3%+81.3%+13.8%-4.0%-4.1%+4.9%

Balance sheet

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash67.2M90.4M95.7M151.2M208.3M300.0M163.5M115.7M116.0M108.4M
Receivables428.6M505.1M491.4M530.8M471.9M489.4M537.3M590.9M594.7M587.8M
Inventory220.4M264.3M264.5M283.4M277.0M327.2M383.4M454.8M476.9M444.8M
Current assets745.6M888.4M884.1M1.0B1.0B1.2B1.1B1.2B1.3B1.2B
Property & equipment273.1M346.4M386.7M398.9M358.6M355.6M353.4M392.8M544.6M516.9M
Goodwill1.1B1.6B1.6B1.6B1.7B1.7B1.8B2.8B3.3B3.3B
Total assets2.4B3.4B3.4B3.5B3.7B3.8B3.8B5.3B6.0B5.9B
Accounts payable75.1M86.0M83.6M85.1M70.9M91.7M99.3M106.3M97.8M121.0M
Current liabilities331.5M647.7M350.3M477.6M363.1M445.4M834.2M582.1M528.5M758.3M
Total debt980.9M1.6B1.3B1.2B1.1B812.4M737.9M1.7B2.2B2.0B
Shareholders' equity851.6M1.2B1.5B1.6B1.8B2.2B2.3B2.6B2.9B3.0B
Retained earnings1.9B2.2B2.5B2.7B2.9B3.3B3.7B4.0B4.3B4.6B

Cash flow

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow334.6M356.8M504.6M382.9M502.4M545.9M513.1M641.3M556.2M719.2M
Capital spending60.9M71.6M89.8M64.2M50.5M38.3M51.4M34.6M64.4M58.1M
Free cash flow273.8M285.2M414.8M318.6M451.9M507.6M461.7M606.7M491.8M661.1M
Stock-based pay (added back)18.2M20.2M21.6M18.1M12.9M22.8M30.7M22.7M19.0M18.9M
Dividends paid56.4M63.8M72.4M82.1M88.3M97.7M125.9M150.4M161.4M179.1M
Buybacks33.4M3.2M24.0M120.5M52.6M61.0M262.9M89.7M33.3M306.4M
Acquisitions42.6M805.9M50.6M12.5M142.4M0171.6M-1.4B-790.0M-
Debt raised261.2M841.5M585.7M186.6M165.7M9.4M63.1M2.2B783.0M25.6M
Debt repaid392.8M237.2M854.5M254.5M319.6M298.8M97.0M1.2B318.7M249.8M
Investing cash flow-102.2M-878.0M-139.9M-76.3M-194.1M-33.2M-222.8M-1.4B-844.4M-26.7M
Financing cash flow-213.8M540.8M-353.7M-251.1M-251.5M-422.9M-416.0M750.5M294.5M-706.4M
Dividend per share0.991.111.251.431.531.692.182.632.823.16

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)18.2M20.2M21.6M18.1M12.9M22.8M30.7M22.7M19.0M18.9M
Stock-based pay / revenue1.0%1.0%1.0%0.8%0.6%1.0%1.2%0.9%0.7%0.7%
Operating lease cost----21.5M20.2M20.4M19.7M20.1M18.9M
Operating lease cash paid----20.9M20.2M20.1M19.8M20.8M19.5M
Finance lease principal paid----7.6M6.6M5.4M6.8M6.1M5.9M
Right-of-use assets---0122.1M110.9M102.3M106.2M93.6M77.5M
Operating lease liabilities---0126.2M114.9M106.5M109.3M97.9M81.9M
Finance lease liabilities----16.5M20.7M16.1M16.6M17.3M14.3M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Next Peers in numbers →